glp-1 news 2025 october 16 KFF's survey of Medicaid officials found state Medicaid programs covered GLP-1s for obesity treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC The Obesity-Drug Revolution Is Stalling

Gissey, P

Meta-analyses show statistically significant but clinically modest reductions in body weight with L-carnitine supplementation, particularly in older adults and those with obesity or metabolic conditions

How to Choose a Reliable Supplier for KPV and BPC-157 Request batch-matched third-party COAs for each compound separately Confirm sequence and molecular weight are explicitly disclosed, not just a purity percentage Look for RUO labeling with no human-use dosing language on either product Ask about US-based manufacturing and quality-control practices Check for a documented policy on batch replacement if a COA doesn't match on arrival Key Takeaways KPV is a small anti-inflammatory tripeptide derived from alpha-MSH

MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data , (2025)

Safety and Considerations Both glutathione and collagen are generally safe when used under medical supervision